SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-20-013554
Filing Date
2020-07-21
Accepted
2020-07-21 21:22:16
Documents
2
Period of Report
2020-07-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3116
2 POWER OF ATTORNEY poa_acosta.htm EX-24 4986
  Complete submission text file 0001567619-20-013554.txt   9427
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST SAN RAFAEL CA 94901
Business Address
Acosta Andrea (Reporting) CIK: 0001818518 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26727 | Film No.: 201040077